Recovery support the combination is often discussed in the context of recovery from exercise, minor injury, or post-procedure healing, which is part of why it comes up frequently alongside our wound care services
Its use is specifically authorized for adults with obesity who also suffer from at least one related health issue, such as type 2 diabetes, high blood pressure, or high cholesterol
Some people cannot tolerate the gastrointestinal effects of GLP-1 medications despite gradual titration and supportive measures
Some users report appetite support and better digestion within weeks, while others require longer periods of consistent use
Top Research Studies on GLP-1s and Cardiovascular Outcomes The November 2023 issue of The New England Journal of Medicine shared results from a research study (SELECT) involving 17,000 patients that showed the use of semaglutide was linked to a 20% reduction in the risk of major adverse cardiovascular events such as heart disease, stroke and peripheral arterial disease in patients who had previously been diagnosed with heart disease
